RA CAPITAL MANAGEMENT, L.P.
Q3 2023 13F-HR Holdings
Net value change ($000)
-254,332
(-4.8%)
New positions
14
Sold out positions
3
Turnover %
18.0%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q2 2023
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| ImmunoGen, Inc. | 167,459 | 380.9% |
| CymaBay Therapeutics, Inc. | 103,475 | NEW |
| EVH | 74,520 | NEW |
| TSHA | 58,373 | NEW |
| ANTX | 57,190 | 178.3% |
| APGE | 42,129 | NEW |
| SLNO | 36,563 | NEW |
| RYTM | 36,526 | 39.0% |
| WAVE LIFE SCIENCES LTD | 36,297 | 58.0% |
| MDGL | 29,865 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| DICE Therapeutics, Inc. | -365,018 | -100.0% |
| CTKB | -105,023 | -100.0% |
| CVAC | -55,175 | -43.2% |
| 89bio, Inc. | -40,073 | -18.5% |
| PEPG | -31,390 | -43.2% |
| VRNA | -30,579 | -22.9% |
| RNAM | -30,225 | -42.5% |
| JBIO | -29,585 | -20.9% |
| MLYS | -23,966 | -44.2% |
| NAMS | -23,760 | -22.2% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|